title: Differentiation and programmed cell death-related intermediate biomarkers for the development of non-small cell lung cancer: a pilot study.
abstract: Fifty samples of lung tissue from patients with non-small cell lung cancer were analyzed for the expression and localization of biomarkers related to squamous differentiation and programmed cell death. These markers include tissue transglutaminase (tTG), keratinocyte transglutaminase (kTG), involucrin, loricrin, and Bcl-2. We found that all of these markers are overexpressed in tumors as compared with histologically normal lung epithelium, where expression is minimal. Expression of the oncoprotein, Bcl-2, increased starting in squamous metaplasia and remained elevated in all lesions, including frank carcinoma. In contrast, expression of the other markers was elevated in the histologically abnormal noninvasive lesions but was decreased somewhat in invasive malignancy. In addition, we found that tTG, kTG, and Bcl-2, when expressed, were detected in mutually exclusive areas. These findings suggest that (1) these markers may prove useful, with more extensive testing and clinical correlation, in predicting risk for the development of lung cancer; and (2) pulmonary carcinogenesis may result from the failure of differentiation and programmed cell death mechanisms in the presence of oncogene overexpression rather than through oncogene/tumor suppressor gene abnormalities alone.
authors.affiliation: Lung Cancer Program, Allegheny University of the Health Sciences-Allegheny Campus, Pittsburgh, PA 15212, USA.
authors.forename: H
authors.initials: H
authors.lastname: Zhang
authors.forename: S A
authors.initials: SA
authors.lastname: Yousem
authors.forename: W A
authors.initials: WA
authors.lastname: Franklin
authors.forename: E
authors.initials: E
authors.lastname: Elder
authors.forename: R
authors.initials: R
authors.lastname: Landreneau
authors.forename: P
authors.initials: P
authors.lastname: Ferson
authors.forename: R
authors.initials: R
authors.lastname: Keenan
authors.forename: T
authors.initials: T
authors.lastname: Whiteside
authors.forename: M L
authors.initials: ML
authors.lastname: Levitt
mesh_terms: D017209:Apoptosis; D015415:Biomarkers / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism* / Q000473:pathology; D002454:Cell Differentiation; D006801:Humans; D007124:Immunoenzyme Techniques; D008168:Lung / Q000166:cytology / Q000378:metabolism*; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D008565:Membrane Proteins / Q000378:metabolism; D010865:Pilot Projects; D011498:Protein Precursors / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D011503:Transglutaminases / Q000378:metabolism
chemical_list: D015415:Biomarkers; D008565:Membrane Proteins; D011498:Protein Precursors; D019253:Proto-Oncogene Proteins c-bcl-2; C064554:loricrin; C032253:involucrin; D011503:Transglutaminases